𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients

✍ Scribed by Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenther Schmutz; Heiko Jessen; Lutwin Weitner; Antonius Mutz; Dietmar Schranz; Juergen K. Rockstroh; for the KAAD study group


Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
162 KB
Volume
53
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pegylated interferon alpha-2b plus ribav
✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of

Treatment of chronic hepatitis C in HIV/
✍ Norbert Bräu; Maribel Rodriguez-Torres; Dale Prokupek; Maurizio Bonacini; Carol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

for the amfAR DCRI 010 Study Group Human immunodeficiency virus (HIV)-infected patients increasingly experience the consequences of chronic hepatitis C virus (HCV) coinfection. This trial randomized 107 patients coinfected with HIV and HCV to receive 48 weeks of interferon alfa-2b (IFN) 3 million un